C4 Therapeutics Company
TORPEDO® platform to design and optimize targeted protein degraders (TPDs).
Funding Status:
IPO
Headquarters:
USA
Industry:
Deep Diagnostics
Estimated Revenue:
$1M to $10M
Technology:
Genetic Test & Molecular Diagnostics
Total Funding:
> $700 M
Founded Date:
2015